Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0411-2025

Drug recall · May 14, 2025

Clindamycin HCl Capsule recall

Why: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Lots / codes

Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.

Quantity
23 bottles/30 count- 690 capsules
Company
RemedyRePack Inc., Indiana, PA
Distribution
Within U.S - PA, VA, FL.
Initiated
April 22, 2025 · Voluntary: Firm initiated
Classified
May 6, 2025
Reported
May 14, 2025
How notified
E-Mail

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Clindamycin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.